[go: up one dir, main page]

ZA916393B - Inhibitors of serine proteases - Google Patents

Inhibitors of serine proteases

Info

Publication number
ZA916393B
ZA916393B ZA916393A ZA916393A ZA916393B ZA 916393 B ZA916393 B ZA 916393B ZA 916393 A ZA916393 A ZA 916393A ZA 916393 A ZA916393 A ZA 916393A ZA 916393 B ZA916393 B ZA 916393B
Authority
ZA
South Africa
Prior art keywords
inhibitors
serine proteases
proteases
serine
Prior art date
Application number
ZA916393A
Other languages
English (en)
Inventor
Rainer Metternich
Metternich Rainer
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA916393B publication Critical patent/ZA916393B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA916393A 1990-08-13 1991-08-13 Inhibitors of serine proteases ZA916393B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017694A GB9017694D0 (en) 1990-08-13 1990-08-13 Improvements in or relating to organic chemistry

Publications (1)

Publication Number Publication Date
ZA916393B true ZA916393B (en) 1993-04-28

Family

ID=10680563

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916393A ZA916393B (en) 1990-08-13 1991-08-13 Inhibitors of serine proteases

Country Status (18)

Country Link
EP (1) EP0471651A3 (fr)
JP (1) JP2539965B2 (fr)
KR (1) KR920004416A (fr)
AU (1) AU643312B2 (fr)
CA (1) CA2048953A1 (fr)
CS (1) CS248491A3 (fr)
FI (1) FI913788L (fr)
GB (1) GB9017694D0 (fr)
HU (1) HUT59161A (fr)
IE (1) IE912841A1 (fr)
IL (1) IL99163A (fr)
MX (1) MX9100628A (fr)
MY (1) MY106529A (fr)
NZ (1) NZ239359A (fr)
PT (1) PT98638B (fr)
RU (1) RU2075481C1 (fr)
TW (1) TW275634B (fr)
ZA (1) ZA916393B (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574014A (en) * 1988-04-28 1996-11-12 Thrombosis Research Institute Inhibitors of trypsin-like enzymes
US6313096B1 (en) 1988-04-28 2001-11-06 Trigen Limited Inhibitors of trypsin-like enzymes
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
MX9206628A (es) * 1991-11-22 1993-05-01 Boehringer Ingelheim Pharma Ester de prolinaboronato y metodo para su preparacion.
EP0636143B1 (fr) * 1992-04-16 1997-09-24 Zeneca Limited Peptides d'acide alpha-aminoboronique et leur utilisation comme inhibiteurs d'elastase
FR2701951B1 (fr) * 1993-02-24 1995-06-09 Adir Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
MY131622A (en) * 1993-03-03 2007-08-30 Novartis Ag Organic compounds
US5563127A (en) * 1993-03-24 1996-10-08 The Dupont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
AU6448794A (en) * 1993-03-24 1994-10-11 Du Pont Merck Pharmaceutical Company, The Boronic acid and ester inhibitors of thrombin
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5783563A (en) * 1993-06-03 1998-07-21 Astra Aktiebolag Method for treatment or prophylaxis of venous thrombosis
US5462964A (en) * 1993-10-20 1995-10-31 The Du Pont Merck Pharmaceutical Company Dipeptide boronic acid inhibitors of trypsin-like enzymes
CA2174311A1 (fr) * 1993-10-07 1995-04-13 Gregory James Pacofsky Boropeptides renfermant de la pyrrolidine substituee, inhibiteurs de la thrombine
IL111176A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them
IL111175A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
US6060462A (en) * 1993-10-20 2000-05-09 Dupont Pharmaceuticals Company Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
GB9401483D0 (en) * 1994-01-26 1994-03-23 Sandoz Ltd Organic compounds
US5693617A (en) * 1994-03-15 1997-12-02 Proscript, Inc. Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
DE4421052A1 (de) 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
FR2721611B1 (fr) * 1994-06-22 1996-09-27 Adir Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent .
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
US6030972A (en) * 1995-02-17 2000-02-29 Basf Aktiengesellschaft Dipeptide amidines as thrombin inhibitors
US5629324A (en) * 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
JP4050316B2 (ja) 1995-07-26 2008-02-20 三菱化学株式会社 ペニシラミンアミド誘導体
GB9515489D0 (en) * 1995-07-28 1995-09-27 Sandoz Ltd Organic compounds
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
FR2745288B1 (fr) * 1996-02-27 1998-04-17 Adir Nouveaux derives de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6004955A (en) * 1996-08-15 1999-12-21 Dupont Pharmaceuticals Company Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists
WO1998016525A1 (fr) * 1996-10-11 1998-04-23 Cor Therapeutics, Inc. INHIBITEURS SELECTIFS DU FACTEUR Xa
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
WO1998016547A1 (fr) * 1996-10-11 1998-04-23 Cor Therapeutics, Inc. INHIBITEURS SELECTIFS DU FACTEUR Xa
US6063794A (en) * 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
CA2268270A1 (fr) * 1996-10-11 1998-04-23 Cor Therapeutics, Inc. Derives heterocycliques utilises comme inhibiteurs de facteur xa
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
NZ500351A (en) * 1997-04-14 2001-10-26 Cor Therapeutics Inc Cyclic diaza compounds as selective factor Xa inhibitors
AU6896298A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
EP0977773A1 (fr) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. INHIBITEURS SELECTIFS DU FACTEUR Xa
AU747531B2 (en) 1997-04-14 2002-05-16 Millennium Pharmaceuticals, Inc. Selective factor Xa inhibitors
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
ES2239806T3 (es) 1997-06-19 2005-10-01 Bristol-Myers Squibb Pharma Company Inhibidores del factor xa con un grupo de especificidad neutro p1.
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
AU743996B2 (en) 1997-09-29 2002-02-14 Point Therapeutics, Inc. Stimulation of hematopoietic cells in vitro
BR9907112A (pt) 1998-01-26 2000-10-24 Basf Ag Composto, medicamento, e, uso de um composto
CA2333927A1 (fr) 1998-04-01 1999-10-07 Dupont Pharmaceuticals Company Antagonistes de l'integrine
JP2002513762A (ja) 1998-05-04 2002-05-14 ポイント セラピューティクス, インコーポレイテッド 造血刺激
DE69905038T2 (de) 1998-06-05 2003-06-05 Point Therapeutics, Inc. Cyclische boroprolinverbindungen
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
CA2348740A1 (fr) 1998-12-23 2000-07-06 Ruth R. Wexler Inhibiteurs de la thrombine ou du facteur xa
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US6727366B2 (en) 2000-12-13 2004-04-27 Bristol-Myers Squibb Pharma Company Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
AU2002230836A1 (en) 2000-12-18 2002-07-01 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
WO2002064559A2 (fr) 2001-02-09 2002-08-22 Merck & Co., Inc. Inhibiteurs de thrombine
ES2258149T3 (es) 2001-05-30 2006-08-16 Novartis Ag Derivados de acido 2-((n-(2-amino-3-(heteroaril o aril)propionil)aminoacil)amino)alquilboronico.
US7084134B2 (en) 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors
US7371729B2 (en) 2002-09-09 2008-05-13 Trigen Limited Boronic acid salts useful in parenteral formulations
JP2006511593A (ja) 2002-09-09 2006-04-06 トライジェン・リミテッド ボロン酸塩および血栓症の治療におけるその使用
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2017222914A1 (fr) 2016-06-21 2017-12-28 Inception 4, Inc. Dérivés de prolinamide carbocycliques
AU2017282651B2 (en) 2016-06-21 2021-08-12 Orion Ophthalmology LLC Heterocyclic prolinamide derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (fr) * 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Inhibiteurs de la rénine
DE3827340A1 (de) * 1988-08-12 1990-02-15 Hoechst Ag Verwendung von (alpha)-aminoboronsaeure-derivaten zur prophylaxe und behandlung von viruserkrankungen
DE3840452A1 (de) * 1988-12-01 1990-06-07 Hoechst Ag (beta)-amino-boronsaeure-derivate

Also Published As

Publication number Publication date
JP2539965B2 (ja) 1996-10-02
EP0471651A3 (en) 1993-02-10
GB9017694D0 (en) 1990-09-26
HUT59161A (en) 1992-04-28
KR920004416A (ko) 1992-03-27
MY106529A (en) 1995-06-30
IL99163A0 (en) 1992-07-15
RU2075481C1 (ru) 1997-03-20
AU8179291A (en) 1992-02-20
AU643312B2 (en) 1993-11-11
FI913788L (fi) 1992-02-14
PT98638B (pt) 1999-01-29
MX9100628A (es) 1994-02-28
HU912541D0 (en) 1992-01-28
CA2048953A1 (fr) 1992-02-14
CS248491A3 (en) 1992-02-19
IE912841A1 (en) 1992-02-26
TW275634B (fr) 1996-05-11
EP0471651A2 (fr) 1992-02-19
IL99163A (en) 1996-01-19
FI913788A0 (fi) 1991-08-09
PT98638A (pt) 1992-06-30
NZ239359A (en) 1993-09-27
JPH04330094A (ja) 1992-11-18

Similar Documents

Publication Publication Date Title
ZA916393B (en) Inhibitors of serine proteases
PL314838A1 (en) Inhibitors of bp-iv-serine protease
CY2164B1 (en) Sulfonamide inhibitors of hiv-aspartyl protease
HU9202842D0 (en) Climotripsine-type proteases and inhibitors
EP0252057A3 (en) Serine protease inhibitors
HU9302080D0 (en) Amine-diole protease inhibitors
ZA939285B (en) Inhibitors of aspartyl protease
AP9701054A0 (en) Inhibitors of cycteine protease
PL313871A1 (en) Inhibitors of hiv protease
FI950168L (fi) Korkea-alkaliset seriiniproteaasit
AU2790895A (en) Purification of serine protease and synthetic inhibitors thereof
PL323710A1 (en) Reversible inhibitors of cysteinic protease
ZA915269B (en) Retroviral protease inhibitors
IL77226A (en) Serine protease inhibitors
IL95810A0 (en) Inhibitors of retroviral proteases
ZA919439B (en) Htv protease inhibitors
PL328665A1 (en) Inhibitors of serinic protease
ZA915271B (en) Inhibitors of retroviral proteases
GB2299583B (en) Peptidyl inhibitors of serine proteases
EP0538374A4 (en) Aspartic protease inhibitors
SG52778A1 (en) Saccharin derivative proteolytic enzyme inhibitors
ZA915270B (en) Inhibitors of aspartic proteases
GB9613719D0 (en) Serine protease inhibitors
ZA941501B (en) Serine protease inhibitors
GB9321696D0 (en) Peptide inhibitors of serine proteinases